AcuCort

AcuCort ROA

The Return on Assets (ROA) of AcuCort (ACUC.SL) as of Oct 18, 2026 is -38.43 %. In the previous year, Return on Assets (ROA) was -23.40 % — a change of 64.23% (lower).

ROA

-38.43 %

YoY

64.23%

Last updated:

In 2024, AcuCort's return on assets (ROA) was -38.43 %, a 64.23% increase from the -23.40 % ROA in the previous year.

The AcuCort ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
-14.80 SEK
Jan 1, 2018
-17.08 SEK
Jan 1, 2019
-14.95 SEK
Jan 1, 2020
-16.42 SEK
Jan 1, 2021
-17.91 SEK
Jan 1, 2022
-29.75 SEK
Jan 1, 2023
-23.40 SEK
Jan 1, 2024
-38.43 SEK
The AcuCort ROA history
YEARROAYoY
-38.43 %+64.23%
-23.40 %-21.35%
-29.75 %+66.09%
-17.91 %+9.11%
-16.42 %+9.82%
-14.95 %-12.48%
-17.08 %+15.40%
-14.80 %+83.89%
-8.05 %-25.32%
-10.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AcuCort Stock analysis

What does AcuCort do? AcuCort AB is a pharmaceutical company based in Lund, Sweden, operating within the Health Care sector. The company focuses on the development, marketing, and sale of oral dissolvable films, specifically targeting medical applications. Its primary product, ISICORT, utilizes dexamethasone, a glucocorticoid, for treating acute allergic reactions and managing nausea and vomiting associated with chemotherapy. AcuCort AB has a small operational footprint, employing four full-time staff members. The company completed its initial public offering (IPO) on April 24, 2017, and is listed under the ticker ACUC.SL with ISIN SE0009695927. It maintains a website at https://acucort.se/ for further information. AcuCort AB operates predominantly in the Nordic region, with its headquarters situated in Lund, Skåne. The company's business model centers on the production and distribution of specialized pharmaceutical products designed to address specific medical needs. While details about its financial performance, market share, or additional product lines are not provided, the company's focus remains on its core product and regional market presence. Its operational scale reflects a startup or early-stage pharmaceutical enterprise with limited resources. The company's website serves as the primary source for updates and corporate information. AcuCort AB's activities are confined to the development and commercialization of oral film technology, emphasizing targeted therapeutic applications in healthcare. AcuCort is one of the most popular companies on Eulerpool.

ROA Details

Understanding AcuCort's Return on Assets (ROA)

AcuCort's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing AcuCort's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider AcuCort's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in AcuCort’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about AcuCort stock

Return on Assets (ROA) of AcuCort is -38.43 % in 2024.

Return on Assets (ROA) of AcuCort changed from -23.40 % to -38.43 %, representing a 64.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) AcuCort since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s AcuCort with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — AcuCort

All Key Metrics — AcuCort